Provectus Biopharmaceuticals, Inc. (PNK:PVCT) Q1 2024 Earnings Call Transcript February 22, 2024 Provectus Biopharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. This is the conference operator. Welcome to the Provectus Biopharmaceuticals First Quarter […]
Constellium SE (NYSE:CSTM) Q4 2023 Earnings Call Transcript February 21, 2024 Constellium SE misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.31. CSTM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Constellium […]
PPL Corporation (NYSE:PPL) Q4 2023 Earnings Call Transcript February 16, 2024 PPL Corporation misses on earnings expectations. Reported EPS is $0.00015 EPS, expectations were $0.38. PPL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]